{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:43:52Z","timestamp":1782182632119,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1053\/j.ajkd.2015.04.046","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T19:56:50Z","timestamp":1433534210000},"page":"396-401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors"],"prefix":"10.1053","volume":"66","author":[{"given":"Leonardo V.","family":"Riella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice M.","family":"Sheridan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1053\/j.ajkd.2015.04.046_bib1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/ajt.12599","article-title":"What are the harms of refusing to allow living kidney donation? An expanded view of risks and benefits","volume":"14","author":"Allen","year":"2014","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1053\/j.ajkd.2015.04.046_bib2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa0804883","article-title":"Long-term consequences of kidney donation","volume":"360","author":"Ibrahim","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1053\/j.ajkd.2015.04.046_bib3","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1056\/NEJMoa1000950","article-title":"Racial variation in medical outcomes among living kidney donors","volume":"363","author":"Lentine","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1053\/j.ajkd.2015.04.046_bib4","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1600-6143.2011.03513.x","article-title":"The APOL1 gene and allograft survival after kidney transplantation","volume":"11","author":"Reeves-Daniel","year":"2011","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1053\/j.ajkd.2015.04.046_bib5","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1681\/ASN.2013010049","article-title":"The effect of race and income on living kidney donation in the United States","volume":"24","author":"Gill","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2015.04.046_bib6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/jama.2013.285141","article-title":"Risk of end-stage renal disease following live kidney donation","volume":"311","author":"Muzaale","year":"2014","journal-title":"JAMA"},{"issue":"7","key":"10.1053\/j.ajkd.2015.04.046_bib7","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.amjmed.2008.11.021","article-title":"White\/black racial differences in risk of end-stage renal disease and death","volume":"122","author":"Choi","year":"2009","journal-title":"Am J Med"},{"issue":"2","key":"10.1053\/j.ajkd.2015.04.046_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1053\/j.ajkd.2013.03.009","article-title":"Lifetime incidence of CKD stages 3-5 in the United States","volume":"62","author":"Grams","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2015.04.046_bib9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ki.2012.263","article-title":"Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans","volume":"83","author":"Lipkowitz","year":"2013","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2015.04.046_bib10","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1681\/ASN.2005111200","article-title":"Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study","volume":"17","author":"McClellan","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1 suppl 1","key":"10.1053\/j.ajkd.2015.04.046_bib11","first-page":"e1","article-title":"US Renal Data System 2013 annual data report","volume":"63","author":"Collins","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1053\/j.ajkd.2015.04.046_bib12","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/ng.232","article-title":"MYH9 is associated with nondiabetic end-stage renal disease in African Americans","volume":"40","author":"Kao","year":"2008","journal-title":"Nat Genet"},{"issue":"10","key":"10.1053\/j.ajkd.2015.04.046_bib13","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/ng.226","article-title":"MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis","volume":"40","author":"Kopp","year":"2008","journal-title":"Nat Genet"},{"issue":"5993","key":"10.1053\/j.ajkd.2015.04.046_bib14","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"issue":"3","key":"10.1053\/j.ajkd.2015.04.046_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","article-title":"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene","volume":"128","author":"Tzur","year":"2010","journal-title":"Hum Genet"},{"issue":"7","key":"10.1053\/j.ajkd.2015.04.046_bib16","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/ki.2012.217","article-title":"Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease","volume":"82","author":"Freedman","year":"2012","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.ajkd.2015.04.046_bib17","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1681\/ASN.2013060589","article-title":"APOL1 and progression of nondiabetic nephropathy","volume":"24","author":"Palmer","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"23","key":"10.1053\/j.ajkd.2015.04.046_bib18","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1056\/NEJMoa1310345","article-title":"APOL1 risk variants, race, and progression of chronic kidney disease","volume":"369","author":"Parsa","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1053\/j.ajkd.2015.04.046_bib19","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1681\/ASN.2013010113","article-title":"APOL1 variants associate with increased risk of CKD among African Americans","volume":"24","author":"Foster","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.ajkd.2015.04.046_bib20","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1681\/ASN.2011050519","article-title":"Population-based risk assessment of APOL1 on renal disease","volume":"22","author":"Friedman","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.ajkd.2015.04.046_bib21","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2015.04.046_bib22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/art.38220","article-title":"End-stage renal disease in African Americans with lupus nephritis is associated with APOL1","volume":"66","author":"Freedman","year":"2014","journal-title":"Arthritis Rheum"},{"issue":"13","key":"10.1053\/j.ajkd.2015.04.046_bib23","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1177\/0961203312460114","article-title":"Collapsing glomerulopathy associated lupus in a black female with homozygous APOL1 mutation","volume":"21","author":"Kofman","year":"2012","journal-title":"Lupus"},{"issue":"5","key":"10.1053\/j.ajkd.2015.04.046_bib24","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1681\/ASN.2012121180","article-title":"Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy","volume":"24","author":"Larsen","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2015.04.046_bib25","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2141.2011.08832.x","article-title":"MYH9 and APOL1 are both associated with sickle cell disease nephropathy","volume":"155","author":"Ashley-Koch","year":"2011","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1053\/j.ajkd.2015.04.046_bib26","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1681\/ASN.2011040434","article-title":"APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy","volume":"22","author":"Papeta","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.ajkd.2015.04.046_bib27","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1681\/ASN.2011010069","article-title":"APOL1 localization in normal kidney and nondiabetic kidney disease","volume":"22","author":"Madhavan","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2015.04.046_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1681\/ASN.2013091017","article-title":"Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines","volume":"26","author":"Ma","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2015.04.046_bib29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1681\/ASN.2004040333","article-title":"Influence of race on kidney transplant outcomes within and outside the Department of Veterans Affairs","volume":"16","author":"Chakkera","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2015.04.046_bib30","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/j.1600-6143.2012.04033.x","article-title":"The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival","volume":"12","author":"Lee","year":"2012","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1053\/j.ajkd.2015.04.046_bib31","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/01.tp.0000277288.78771.c2","article-title":"Living kidney donors requiring transplantation: focus on African Americans","volume":"84","author":"Gibney","year":"2007","journal-title":"Transplantation"},{"issue":"1","key":"10.1053\/j.ajkd.2015.04.046_bib32","first-page":"58","article-title":"Effects of socioeconomic factors on obesity rates in four southern states and Colorado","volume":"21","author":"Akil","year":"2011","journal-title":"Ethn Dis"},{"issue":"11","key":"10.1053\/j.ajkd.2015.04.046_bib33","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nrcardio.2009.163","article-title":"Socioeconomic status and cardiovascular disease: risks and implications for care","volume":"6","author":"Clark","year":"2009","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1053\/j.ajkd.2015.04.046_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1037\/0002-9432.75.1.3","article-title":"Socioeconomic status and mental illness: tests of the social causation and selection hypotheses","volume":"75","author":"Hudson","year":"2005","journal-title":"Am J Orthopsychiatry"},{"issue":"9","key":"10.1053\/j.ajkd.2015.04.046_bib35","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrneph.2012.117","article-title":"Influence of race, ethnicity and socioeconomic status on kidney disease","volume":"8","author":"Patzer","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2015.04.046_bib36","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1037\/0033-2909.105.2.260","article-title":"Socioeconomic status and obesity: a review of the literature","volume":"105","author":"Sobal","year":"1989","journal-title":"Psychol Bull"},{"issue":"1","key":"10.1053\/j.ajkd.2015.04.046_bib37","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ki.2013.460","article-title":"Long-term risks for kidney donors","volume":"86","author":"Mjoen","year":"2014","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2015.04.046_bib38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/ki.2013.560","article-title":"End-stage renal disease in living kidney donors","volume":"86","author":"Boudville","year":"2014","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2015.04.046_bib39","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1053\/j.ajkd.2013.12.014","article-title":"APOL1 polymorphisms and development of CKD in an identical twin donor and recipient pair","volume":"63","author":"Kofman","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1053\/j.ajkd.2015.04.046_bib40","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/TP.0b013e31822eec39","article-title":"African American living-kidney donors should be screened for APOL1 risk alleles","volume":"92","author":"Cohen","year":"2011","journal-title":"Transplantation"},{"issue":"3","key":"10.1053\/j.ajkd.2015.04.046_bib41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJMoa0809578","article-title":"Disclosure of APOE genotype for risk of Alzheimer's disease","volume":"361","author":"Green","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2015.04.046_bib42","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/ng0803-347","article-title":"Genomic profiling to promote a healthy lifestyle: not ready for prime time","volume":"34","author":"Haga","year":"2003","journal-title":"Nat Genet"},{"issue":"11","key":"10.1053\/j.ajkd.2015.04.046_bib43","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.299.11.1353","article-title":"Genomic profiles for disease risk: predictive or premature?","volume":"299","author":"Offit","year":"2008","journal-title":"JAMA"},{"issue":"3","key":"10.1053\/j.ajkd.2015.04.046_bib44","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/ndt\/gft423","article-title":"Gene-gene interactions in APOL1-associated nephropathy","volume":"29","author":"Divers","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"15","key":"10.1053\/j.ajkd.2015.04.046_bib45","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1097\/QAD.0b013e328357f5ed","article-title":"Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care","volume":"26","author":"Kalayjian","year":"2012","journal-title":"AIDS"},{"issue":"11","key":"10.1053\/j.ajkd.2015.04.046_bib46","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.2215\/CJN.01330214","article-title":"Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy","volume":"9","author":"Freedman","year":"2014","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263861500760X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263861500760X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:37:30Z","timestamp":1759459050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027263861500760X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S027263861500760X"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2015.04.046","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2015.04.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}